Arrowhead Pharmaceuticals, Inc. (ARWR)
56.60
+0.70
(+1.25%)
USD |
NASDAQ |
Oct 19, 15:05
Arrowhead Pharmaceuticals Market Cap : 7.988B for Oct. 19, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 7.889B |
| October 15, 2026 | 8.256B |
| October 14, 2026 | 8.238B |
| October 13, 2026 | 8.204B |
| October 12, 2026 | 8.571B |
| October 09, 2026 | 8.856B |
| October 08, 2026 | 8.573B |
| October 07, 2026 | 8.677B |
| October 06, 2026 | 8.685B |
| October 05, 2026 | 8.800B |
| October 02, 2026 | 9.059B |
| October 01, 2026 | 9.144B |
| September 30, 2026 | 9.237B |
| September 29, 2026 | 9.350B |
| September 28, 2026 | 9.239B |
| September 25, 2026 | 9.304B |
| September 24, 2026 | 9.325B |
| September 23, 2026 | 9.450B |
| September 22, 2026 | 10.14B |
| September 21, 2026 | 9.709B |
| September 18, 2026 | 9.383B |
| September 17, 2026 | 9.560B |
| September 16, 2026 | 9.285B |
| September 15, 2026 | 9.974B |
| September 14, 2026 | 11.39B |
| Date | Value |
|---|---|
| September 11, 2026 | 11.69B |
| September 10, 2026 | 11.68B |
| September 09, 2026 | 11.66B |
| September 08, 2026 | 12.01B |
| September 04, 2026 | 12.19B |
| September 03, 2026 | 12.21B |
| September 02, 2026 | 12.05B |
| September 01, 2026 | 11.68B |
| August 31, 2026 | 11.63B |
| August 28, 2026 | 11.98B |
| August 27, 2026 | 12.50B |
| August 26, 2026 | 12.58B |
| August 25, 2026 | 12.54B |
| August 24, 2026 | 12.24B |
| August 21, 2026 | 12.29B |
| August 20, 2026 | 12.35B |
| August 19, 2026 | 12.62B |
| August 18, 2026 | 12.41B |
| August 17, 2026 | 12.52B |
| August 14, 2026 | 12.23B |
| August 13, 2026 | 12.08B |
| August 12, 2026 | 12.31B |
| August 11, 2026 | 12.59B |
| August 10, 2026 | 12.47B |
| August 07, 2026 | 12.37B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 90.51B |
| Sarepta Therapeutics, Inc. | 1.865B |
| Revolution Medicines, Inc. | 39.03B |
| Intellia Therapeutics, Inc. | 1.606B |
| Twist Bioscience Corp. | 8.719B |
Market Cap Related Metrics
| PS Ratio | 11.88 |
| PEG Ratio | -0.3254 |
| Price to Book Value | 17.16 |
| Price | 56.60 |
| Earnings Yield | -3.96% |
| PEGY Ratio | -0.3254 |